Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

    Dual blockade of HER2 promises increased pathological complete response (pCR) rate compared with single blockade in the presence of chemotherapy for HER2-positive (+) primary breast cancer. Many questions rema...

    N. Masuda, M. Toi, N. Yamamoto, H. Iwata, K. Kuroi, H. Bando, S. Ohtani in Breast Cancer (2018)

  2. No Access

    Article

    Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

    HLA-DRB1*07:01 allele carriage was characterised as a risk biomarker for lapatinib-induced liver injury in a large global study evaluating lapatinib, alone and in combination with trastuzumab and taxanes, as adju...

    C F Spraggs, L R Parham, L P Briley, L Warren, L S Williams in The Pharmacogenomics Journal (2018)

  3. Article

    Open Access

    Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis

    We analysed the vascular morphology of the palm using a photoacoustic tomography (PAT) instrument with a hemispherical detector array. The three-dimensional (3D) morphology of blood vessels was determined noni...

    Y. Matsumoto, Y. Asao, A. Yoshikawa, H. Sekiguchi, M. Takada, M. Furu in Scientific Reports (2018)

  4. No Access

    Article

    Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)

    This retrospective study evaluated the effect of clinical background and treatment line on time to treatment failure (TTF) in advanced/metastatic breast cancer (AMBC) patients receiving F500 in Japan (UMIN 000...

    H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi in Breast Cancer Research and Treatment (2017)

  5. Article

    Open Access

    Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array

    Noninvasive measurement of the distribution and oxygenation state of hemoglobin (Hb) inside the tissue is strongly required to analyze the tumor-associated vasculatures. We developed a photoacoustic imaging (P...

    M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada in Scientific Reports (2017)

  6. No Access

    Chapter

    Assessing Tumor Angiogenesis in Histological Samples

    Angiogenesis is a hallmark of cancer [1] and occurs in most human tumors. It has been shown that angiogenic tumors are more likely to develop metastasis and exhibit resistance to standard cancer therapies [2],...

    E. Fakhrejahani, M. Toi in Handbook of Vascular Biology Techniques (2015)

  7. No Access

    Article

    A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

    Better treatments for triple-negative breast cancer (TNBC) are needed. To address this need, we studied the effects of preoperative metronomic paclitaxel/cyclophosphamide/capecitabine (mPCX) followed by 5-fluo...

    N. Masuda, K. Higaki, T. Takano, N. Matsunami in Cancer Chemotherapy and Pharmacology (2014)

  8. No Access

    Article

    Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)

    We investigated the disease-free survival (DFS) of HER2-positive primary breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab, as well as predictive factors for DFS and pathologic resp...

    M. Takada, H. Ishiguro, S. Nagai, S. Ohtani in Breast Cancer Research and Treatment (2014)

  9. Article

    Open Access

    Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

    This randomized, multicenter study compared the efficacy of docetaxel with or without capecitabine following fluorouracil/epirubicin/cyclophosphamide (FEC) therapy in operable breast cancer and investigated t...

    S. Ohno, L. W. C. Chow, N. Sato, N. Masuda in Breast Cancer Research and Treatment (2013)

  10. Article

    Open Access

    Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients

    Frozen gloves (FG) are effective in preventing docetaxel-induced nail toxicity (DNT), but uncomfortable. The preventive effect of FG for DNT was compared using a standard (−25 to −30°C) or more comfortable (−1...

    H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto in Supportive Care in Cancer (2012)

  11. No Access

    Article

    Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique

    Nomogram, a standard technique that utilizes multiple characteristics to predict efficacy of treatment and likelihood of a specific status of an individual patient, has been used for prediction of response to ...

    M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato in Breast Cancer Research and Treatment (2012)

  12. Article

    Open Access

    Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer

    A blood pressure drop after bevacizumab administration and its clinical significance have not been previously reported.

    M Kanai, H Ishiguro, Y Mori, T Kitano, T Nishimura in British Journal of Cancer (2011)

  13. No Access

    Article

    Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey

    Steroids and H2 blockers are commonly used as supportive care for taxane-containing chemotherapy, but they also affect docetaxel’s primary metabolizer, cytochrome P450 3A4. This retrospective observational study ...

    K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura in Breast Cancer Research and Treatment (2011)

  14. Article

    Open Access

    Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies

    HER2-positive metastatic breast cancer (MBC) relapsing after trastuzumab-based therapy may require continued HER2 receptor inhibition to control the disease and preserve the patients' quality-of-life. Efficacy...

    M Toi, H Iwata, Y Fujiwara, Y Ito, S Nakamura, Y Tokuda in British Journal of Cancer (2009)

  15. Article

    Open Access

    Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan

    Raloxifene was approved for chemoprevention against breast cancer among high-risk women in addition to tamoxifen by the US Food and Drug Administration. This study aims to evaluate cost-effectiveness of these ...

    M Kondo, S-L Hoshi, M Toi in British Journal of Cancer (2009)

  16. Article

    Open Access

    Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer

    Vascular endothelial growth factor (VEGF) receptors consist of three cell-membrane type receptors (VEGFR-1, VEGFR-2 and VEGFR-3), and soluble form of VEGFR-1 (sVEGFR-1), an intrinsic negative counterpart of th...

    H Bando, H A Weich, M Brokelmann, S Horiguchi, N Funata in British Journal of Cancer (2005)

  17. Article

    Open Access

    Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer

    The combination effect of docetaxel and capecitabine on tumour response rate and survival was demonstrated recently in metastatic breast cancer patients. This combination was based on an experimental hypothesi...

    M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno in British Journal of Cancer (2004)

  18. No Access

    Article

    Fascin-positive dendritic cells and fibroblastic reticulum cells build a framework of T-cell areas in lymph nodes

    Fascin, a 55-kDa actin-bundling protein, and α-smooth muscle actin (ASMA) were immunohistochemically examined in murine normal and stimulated lymph nodes. In specific pathogen-free young female mice, a few fas...

    M. Hiroi, N. Kuroda, M. Toi, Y. Hayashi, E. Miyazaki, K. Naruse in Virchows Archiv (2004)

  19. No Access

    Article

    A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera

    We have developed an apoptosis assay based on measurement of a neoepitope of cytokeratin-18 (CK18-Asp396) exposed after caspase-cleavage and detected by the monoclonal antibody M30. The total amount of caspase...

    K. Bivén, H. Erdal, M. Hägg, T. Ueno, R. Zhou, M. Lynch, B. Rowley, J. Wood in Apoptosis (2003)

  20. Article

    Open Access

    Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

    Tissue factor (TF), an initiator of the extrinsic coagulation cascade, is expressed in a wide range of cancer cells and plays important roles in cancer progression and metastasis. Recently, the intracellular f...

    T Ueno, M Toi, M Koike, S Nakamura, T Tominaga in British Journal of Cancer (2000)

previous disabled Page of 2